Alkermes' Corporate Presentation to Be Webcast at the Morgan Stanley Global Healthcare Conference

DUBLIN--(BUSINESS WIRE)--

Alkermes plc ALKS announced today that its corporate presentation will be webcast live at the Morgan Stanley Global Healthcare Conference on Thursday, Sept. 17, 2015, at 11:10 a.m. EDT (4:10 p.m. BST) from the Grand Hyatt New York. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Alkermes plc
Sandra Coombs, +1-781-609-6377
Corporate Communications

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!